Guest Host: Katty Kay

A new drug has been approved by the F.D.A. to treat fibromyalgia, a condition characterized by chronic and widespread pain. We’ll talk about some of the ongoing questions related to its diagnosis and treatment.


  • Frances Bremer Spokesperson, National Fibromyalgia Association
  • Dr. Nortin Hadler Professor of Medicine and Microbiology/Immunology University of North Carolina at Chapel Hill Attending Rheumatologist, UNC Hospitals
  • Alex Berenson Reporter, New York Times
  • Dr. Patrick Wood Researcher and clinician specializing in fibromyalgia, chief medical officer of Angler Biomedical Technologies

Related Links


comments powered by Disqus
Most Recent Shows